Inhibition of mitochondrial oxidative phosphorylation induces hyper-expression of glutamic acid decarboxylase in pancreatic islet cells

Autoimmunity

Volumn 30, Issue 1, 1999, Pages 43-51

  Myers, Mark A ^a   Georgiou, Harry M ^b   Byron, Sarah ^a   Esposti, Mauro Degli ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Glutamic acid decarboxylase; IDDM autoantigens; Mitochondria; Respiratory inhibitors

Indexed keywords

ARGININE; AUTOANTIGEN; GLUCOSE; GLUTAMATE DECARBOXYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FETUS; HAMSTER; INSULIN DEPENDENT DIABETES MELLITUS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET CELL;

EID: 0033030186     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908994759     Document Type: Article

References (34)

1. P. Maechler, E.D. Kennedy, T. Pozzan and C.B. Wollheim. Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic β-cells. EMBO J. (1997) 16: 3833-3841.
2. K.D. Gerbitz, J.M.W. Van den Ouweland, J.A. Maassen and M. Jaksh. Mitochondrial diabetes mellitus. A review. Biochim. Biophys. Acta (1995) 1271: 253-260.
3. I.D. Dukes, M.S. McIntyre, R.J. Mertz, L.H. Philipson, M.W. Roe, B. Spencer, J.F. Worley. Dependence on NADH produced during glycolysis for β-cell glucose signaling. J. Biol. Chem. (1994) 269: 10979-10982.
4. K.D. Gerbitz, K. Gempel and D. Brdiczka. Mitochondria and diabetes - Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes (1996) 45: 113-126.
5. T. Kobayashi, Y. Oha, A. Falorni, A. Kasuga, I. Takei, K. Nakanishi, T. Murase, K. Kosaka and A. Lernmark. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia (1996) 39: 1196-1200.
6. P.M. Matschinsky. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes (1996) 45: 223-241.
7. M. Degli Esposti, A. Ngo and M.A. Myers. Inhibition of mitochondrial complex I may account for the insulin-dependent diabetes induced by intoxication with the rodenticide Vacor. Diabetes (1996) 45: 1531-1534.
8. M.A. Atkinson, and N.K. Maclaren. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. (1996) 92: 1608-1616.
9. M. Degli Esposti and I.R. Mackay. The GABA network and the pathogenesis of IDDM. Diabetologia (1997) 40: 352-356.
10. M. Erecinska, J. Bryla, M. Michalik, M.D. Meglasson and D. Nelson. Energy metabolism in islets of Langerhans. Biochim. Biophys. Acta (1992) 1101: 273-295.
11. O. Kampe, A. Andersson, E. Bjork, A. Hallberg and F.A. Karlsson. High glucose stimulation of 64,000-Mw islet cell autoantigen expression. Diabetes (1989) 38: 1326-1328.
12. E. Bjork, O. Kampe, A. Andersson and F.A. Karlsson. Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia (1992) 32: 490-493.
13. L.A. Velloso, E. Bjork, A.E. Ballagi, K. Funa, A. Andersson, O. Kampe, F.A. Karlsson and D.L. Eizirik. Regulation of GAD expression in islet of Langerhans occurs both at the mRNA and protein level. Mol. Cell. Endocrinol. (1994) 102: 31-37.
14. K. Aaen, J. Rygaard, K. Josefsen, H. Petersen, C. Brogren, T. Horn and K. Buschard. Dependence of antigen expression on functional state of β-cells. Diabetes (1990) 39: 697-701.
15. L.A. O'Relly and A. Cooke. Animal models of insulin dependent diabetes mellitus. In: Bona, C.A., Siminovitch, K.A., Zanetti, M. and Theofilopoulos, A.N. (Eds.) The Molecular Biology of Autoimmune Diseases. Harwood Academic Chur., Switzerland (1993) pp. 619-625.
16. A. Lernmark. Glutamic acid decarboxylase - gene to antigen to disease. J. Int. Med. (1996) 240: 259-277.
17. T.E. Mandel, L. Hoffman and W.M. Carter. Long-term isografts of cultured foetal mouse pancreatic islets: the oncogenic effects of streptozotocin and the prevention of diabetic renal complications. Am. J. Pathol. (1981) 104: 227-236.
18. H.M. Georgiou and T.E. Mandel. Islet cell subpopulations in cultured mouse foetal pancreas and pancreatic isografts. Transplant Proc. (1984) 16: 1055-1056.
19. M. Degli Esposti, A. Ghelli, M. Ratta, D. Cortes and E. Estornell. Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). Biochem. J. (1994) 301: 161-167.
20. U. Brandt and B.L. Trumpower. The protonmotive Q cycle in mitochondria and bacteria. CRC Critic. Rev. Biochem. (1992) 29: 165-197.
21. P.C. Mowery, B.A. Ackrell and T.P. Singer. Carboxins: powerful selective inhibitors of succinate oxidation in animal tissues. Biochem. Biophys. Res. Commun. (1976) 71: 354-361.
22. J. Segovia, J.K. Tillakaratne, A.J. Tobin, K. Gale. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway. Brain Res. (1990) 529: 345-358.
23. C. Burkhardt, J.P. Kelly, Y. Lim, C.M. Filley and W.D.J. Parker. Neuroleptic medications inhibit complex I of the electron transport chain. Ann. Neurol. (1993) 33: 512-517.
24. J.H. Karam, P.A. Lewitt, C.W. Young, R.E. Nowlain, B.J. Frankel, H. Fujiya, Z.R. Freedman and G.M. Grodsky. Insulinopenic diabetes after rotenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes (1980) 29: 971-978.
25. M.A. Myers, D.U. Rabin and M.J. Rowley. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes (1995) 44: 1290-1295.
26. M.A. Myers. Direct measurement of cell numbers in microtitre plate cultures using the fluorescent dye SYBR green I. J. Immunol. Methods (1998) 212: 99-103.
27. B. Ziegler, M. Schlosser, F. Luhder, M. Strebelow, P. Augstein, W. Northemann, A.C. Powers and M. Ziegler. Murine monoclonal glutamic acid decarboxylase (GAD) 65 antibodies recognise autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and Stiff-man syndrome. Acta Diabetol. (1996) 33: 225-231.
28. + channels: generating excitement in pancreatic β-cells. Diabetes (1996) 45: 845-853.
29. K. Tanigawa, J. Kashiwada, K. Tamura, M. Kawaguchi, Y. Seino and Y. Kato. Differential insulin secretory activity in rat pancreatic islet and HIT cells. Diabetes Res. (1994) 26: 1-11.
30. R.S. Schmidli, E. Faulker-Jones, L.C. Harrison, R.F.L. James and H.J. DeAizpurua. Cytokine regulation of glutamate decarboxylase biosynthesis in isolated rat islets of Langerhans. Biochem. J. (1996) 317: 713-719.
31. E. Bjork, O. Kampe, J. Grawe, A. Hallberg, I. Norheim and F.A. Karlsson. Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity. Autoimmunity (1993) 16: 4181-4188.
32. H.J. Romijn, A.W.J.W. Janszen and C. Van der Bogert. Permanent increase of immunocytochemical reactivity for γ-aminobutyric acid (GABA), glutamic acid decarboxylase, mitochondrial enzymes, and glial fibrillary acidic protein in rat cerebral cortex damaged by early postnatal hypoxia-ischemia. Acta Neuropathol. (1994) 87: 612-627.
33. S.C. Shah, J.I. Malone and N.E. Simpson. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N. Engl. J. Med. (1989) 320: 550-554.
34. F. Homo-Delarche and C. Boitard. Autoimmune diabetes: the role of the islets of Langerhans. Immunol. Today (1996) 17: 456-460.